Home   |  Publications   |   Conferences    |  Join   |   Contact   | Sitemap  
Facebook    Twitter     Linkedin     RSS     Google+    BLOG    You Tube

Journal of Cancer Science & Therapy

Open Access
ISSN: 1948-5956
French Language  |  English
SCImago Journal & Country Rank

Upcoming Event


In Association with


About the Journal

Sudhakar Akul Yakkanti, PhD
Impact Factor: 4.203*
H-Factor: 7
Index Copernicus Value: 5.13
flyer image
Cancer is a pathological condition, where assemblage of cells displays uncontrolled growth, invasion and sometimes metastasis. Starting from diagnosis, therapy, and post therapy procedures, cancer treatment involves various Medical, Clinical, Pathological, Psychological approaches with several implications. Cancer research and Tumors science hence is an ever growing literature with the advancement of new therapeutic solutions to prevent, handle and fight it effectively.
Information plays a pivotal role at every stage of the cancer treatment and prevention. The Journal of Cancer Research and therapy (JCST) is a peer reviewed journal that offers a platform that accommodates a wide range of fields in its discipline for the authors to make their contribution towards the journal where the editorial office promises a quick and value added review process for the submitted manuscripts for the quality of publishing.
JCST is an Open Access publishing journal that aims to publish most complete and reliable source of information on the discoveries and current developments in the form of original articles, review articles, case reports, short communications, etc. related to Cancer research and therapy and making them freely available through online without any restrictions or any other subscriptions to researchers worldwide.
This top best open access journal is using Editorial Manager® System for quality in review process. Editorial Manager® is an online manuscript submission, review and tracking systems. Review processing is performed by the editorial board members of the JCST or outside experts; at least two independent reviewers approval followed by editor approval is required for acceptance of any citable manuscript. Authors may submit manuscripts and track their progress through the system. Reviewers can download manuscripts and submit their opinions to the editor. Editors can manage the whole submission/review/revise/publish process.
OMICS Group International is a leading Open Access publisher that publishes more than 400 peer-reviewed Open Access Journals and organizes over 300 International Conferences globally with the support of nearly 1000 International Societies. OMICS Publishing Group journals have over 3 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 30000 eminent personalities and the rapid, quality and quick review processing.
Journal of Cancer Science and Therapy is supporting 5th World congress on Cancer Therapy which is going to be held during September 28-30, 2015, at Atlanta, USA. The theme of the conference is “Emerging Therapeutic advances in cancer therapy”.
Submit manuscript at http://www.editorialmanager.com/cancerscience/ or send as an e-mail attachment to the Editorial Office at editor.jcst@omicsonline.org or editor.jcst@omicsgroup.biz
*Unofficial 2013 Impact Factor was established by dividing the number of articles published in 2011 and 2012 with the number of times they are cited in 2013 based on Google search and the Scholar Citation Index database. If ‘X’ is the total number of articles published in 2011 and 2012, and ‘Y’ is the number of times these articles were cited in indexed journals during 2013 than, impact factor = Y/X



Recently published articles

Bioinformatics Analyses of m-RNA Profiling Following Ezrin Knockdown in Esophageal Squamous Cell Carcinoma

Bingli Wu, Chunquan Li, Jianjun Xie, Zepeng Du, Liewei Luo, Jianyi Wu, Pixian Zhang, Liyan Xu and Enmin Li

Ossifying Fibromyxoid Tumour of Soft Tissues: A Rare Case Report

Panicker NK, Archana C Buch, Kunal Garg and Vijay H Satav

Are Surgical Margins Significant in Assessing the Prognostic Markers for Lymph Node Metastases?

Vimi Sunil Mutalik

Identification of Histone Epigenetic Modifications with Chromatin Immunoprecipitation PCR Array in Chronic Lymphocytic Leukemia Specimens

Gwen Jordaan, Wei Liao, Natalie Coriaty and Sanjai Sharma

Ascorbic Acid in Cancer: A Renewed Hope?

Sunil Rangarajan, Bhuvana Sunil and Lisa M Curtis

Distinct Gene Mutations, their Prognostic Relevance and Molecularly Targeted Therapies in Acute Myeloid Leukemia (AML)

Muhammad Tayyab, Mahwish Khan, Tanveer Akhtar, Zafar Iqbal, Sara Altaf, Zain Noor and Nida Noor

Novel Targeted Therapies in Ovarian Cancer

Laurie Elit and Hal Hirte

Bringing p53 into the Clinic

Ern Yu Tan and Chit Fang Cheok

EDL-360: A Potential Novel Antiglioma Agent

Amira Hosni-Ahmed, Michelle Sims, Terreia S Jones, Renukadevi Patil, Shivaputra Patil, Hossam Abdelsamed, Ryan Yates, Duane D Miller and Lawrence M Pfeffer

Mesothelioma and Hypoxia: Modulation of the Inflammation-Related Phenotype and Identification of Prognostic Markers

Linda Ravenna, Irene Cardillo, Gianfranca Curzio, Alfonso Baldi, Manlio Mattioni, Bruno Vincenzi, Matteo Antonio Russo, Silvia Soddu and Alessandra Verdina

20082014 OMICS Group - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version